Molecular Diagnostics Market to Expand at CAGR 12.1% during 2021 - 2028

The molecular diagnostics market is projected to grow from US$ 16,258.97 million in 2021 to US$ 36,176.65 million by 2028; it is expected to grow at a CAGR of 12.1% during 2021-2028.

Point-of-care (POC) is one emerging healthcare service, which is being aggressively adopted by patients and healthcare service providers alike. It is extensively used in various healthcare processes, such as treatment, diagnostics, and patient monitoring. Leading medical device manufacturers and players in associated markets are actively involved in product innovation and development processes.

The Molecular Diagnostics Market research report provides an in depth examination of the key factors stimulating market expansion. It also sheds light on the challenges or restraining factors that are poised to hinder industry growth over the forecast timeframe. Growth rate, market share captured, and valuation estimates for each region, segment, and company are documented as well.

Get Sample PDF Copy of Molecular Diagnostics Market at: https://www.theinsightpartners.com/sample/TIPRE00003124/?utm_source=OpenPr&utm_medium=10545

List of Companies operating in this report are:
• Abbott
• Agilent Technologies, Inc.
• Thermo Fisher Scientific Inc.
• F. Hoffmann-La Roche Ltd.
• TBG Diagnostics Limited
• QIAGEN
• bioMérieux SA
• Siemens Healthineers AG
• Illumina, Inc.
• Danaher
• Novartis AG

Furthermore, the market is segmented based on Disease Area, Product and Services, End-User and region in order to study it exhaustively and provide the data in a systematic manner. Speaking of competitive landscape, the study includes a list of leading companies along with their product and service offerings, strategic decisions, SWOT analysis, latest developments, market share captured, growth rate, and valuation. The challenges faced by these companies are analyzed and solutions for them are given as well.

Disease Area-Based Insights
By disease area, the molecular diagnostics market is bifurcated into oncology, infectious diseases, genetic testing, cardiac diseases, immune system disorders, and others. In 2021, the infectious disease segment held a larger share of the market. Moreover, the market for the oncology segment is expected to grow at a faster CAGR of 12.5% during 2021-2028.

Product and Services -Based Insights
The molecular diagnostics market, by assays and kits, instruments, services and software. In 2021, the assays and kits segment held the largest share of the market. Moreover, the market for the same segment is expected to grow at the fastest CAGR of 3.5% during 2021-2028.

End-User-Based Insights
The molecular diagnostics market, based on end user, is segmented into hospitals and clinics, diagnostic laboratories, research and academic institutes, and others. In 2021, the diagnostic laboratories segment held the largest share of the market. Moreover, the market for the same segment is expected to grow at the fastest CAGR of 12.5% during 2021-2028.

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global Molecular Diagnostics Market based on various segments. It also provides market size and forecast estimates from the year 2021 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The Molecular Diagnostics market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

Have Question? Speak to Analyst at: https://www.theinsightpartners.com/speak-to-analyst/TIPRE00003124?utm_source=OpenPr&utm_medium=10545

Several market forces such as drivers and restraints and political, social, economic and technological advancements help shape up the industry in specific manner. All such forces are studied in detail to arrive at a market forecast which can help build the investment strategies in Molecular Diagnostics market.

Essential points covered in Molecular Diagnostics market report are:-
1 What will the market size and the growth rate be in 2028?
2 What are the key growth stimulants of Molecular Diagnostics market?
3 What are the key market trends impacting Molecular Diagnostics market valuation?
4 What are the challenges to market proliferation?
5 Who are the key vendors in the Molecular Diagnostics market?
6 Which are the leading companies contributing to Molecular Diagnostics market valuation?
7 What was the market share held by each region in 2028?
8 What is the estimated growth rate and valuation of Molecular Diagnostics market in 2028?

Order a Copy of Molecular Diagnostics Market Share, Strategies and Forecasts 2021-2028 Research Report at: https://www.theinsightpartners.com/buy/TIPRE00003124/?utm_source=OpenPr&utm_medium=10545

About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.

Contact Us:
If you have any queries about this report or if you would like further information, please contact us:
Contact Person: Sameer Joshi
E-mail: sales@theinsightpartners.com
Phone: +1-646-491-9876

This release was published on openPR.